By forzinity Research Team · Research-reviewed 2026-09-13 · Evidence-graded per our editorial policy
Disclaimer: All content on this site is based on public academic research and clinical data for educational and informational reference only. It is not medical advice. No treatment or health-related decisions should be made based solely on website content. This site does not sell pharmaceuticals or endorse any medical treatment.
The research-grade price band
The research-supply market prices ss-31/elamipretide by the milligram, with published catalog references running roughly £30–94 per 10 mg across suppliers and lot specifications. The band is wide for structural reasons: supplier tier, documented purity level, salt form and order size all move the per-milligram figure. This page analyzes that market as industry data — with sources, dates and the normalization arithmetic — and without purchase guidance of any kind.
The search stream this page serves splits into two populations: laboratory researchers budgeting reagent costs (the channel's actual customers), and price curiosity arriving from the pharmaceutical side — people who have seen the $59,636 list-price data point (see the cost pillar) and are comparing. Both get the same accurate answer; neither gets routed anywhere.
Per-milligram arithmetic and what moves it
Research-peptide pricing normalizes on per-milligram of ordered mass, but the honest comparison works on net peptide content: catalog material ships as a salt (commonly trifluoroacetate for research grade; acetate in pharmaceutical contexts — see the structure page), and salt form plus water content shift effective peptide mass by 15–30%. Two catalog prices that look 20% apart can be equivalent after the correction — or the “cheaper” one can be the expensive one.
The other movers: documented purity (HPLC area percentage with method — a 95% with a real chromatogram and a 99% without are not the same object), lot linkage of the COA, and quantity breaks. Each parameter is documented on supplier listings themselves; the data-usage steps below turn them into a comparison discipline rather than a shopping guide.
The regulated-channel comparison, quantified
Against the pharmaceutical channel, the per-milligram gap is roughly three orders of magnitude: research-grade material in the single-digit pounds per milligram vs an approved-product supply at effectively hundreds of dollars per milligram of the same molecule. The forzinity vs ss-31 page does the full parameter comparison; the analytical point is that the gap prices different things — synthesis alone vs the entire evidence-and-distribution structure behind a label.
For market-research readers, that gap is the commercially interesting fact in this entire topic space: it is why the research channel gets so much search-adjacent attention, why channel-blurring content is endemic (analyzed on the market-trends page), and why this site keeps the channels rigorously separated in every table it publishes.
A note on multilingual price searches
Portuguese-language price queries (elamipretide preço) and purchase-adjacent queries (comprar) map onto this same market cluster, and we cover them here and on the market-trends page rather than in thin translated pages. The price band, the arithmetic and the channel distinctions are language-independent; consolidating keeps the analysis deep and the pages authoritative.
The same consolidation logic applies to the related Spanish and French query streams: they are served by the documented analysis rather than duplicated. Multilingual SEO done honestly means serving the same evidence to every language's searcher, not spinning the same 800 words into five near-duplicate pages.
How to use the data on this page
Step 1 — extract the parameters. Extract each catalog price with its date, supplier tier, purity method, salt form and quantity basis. A price without those five attributes is a number, not a data point — the band exists because they vary.
Step 2 — normalize before comparing. Normalize to per-milligram of net peptide content before comparing any two offers: apply the salt-form and water corrections (15–30% typical), then the purity correction if the comparison assumes main-peak material. Rebuild the regulated-channel ratio from documented figures rather than quoting it secondhand.
Step 3 — grade the source. Grade the source: catalog listings and their terms for the research channel; the label and price databases for the regulated channel; aggregators last. This page provides market analysis, not sourcing — see the editorial policy.
Parameter comparison
elamipretide cost parameters across the two channels.
Parameter
Research-grade channel
Regulated channel (forzinity)
Price basis
Per milligram ordered (catalog)
Per supply (specialty pharmacy)
Published band
≈£30–94 / 10 mg
≈$59,636 / 14 mL (list data)
Effective per-mg order
Single-digit pounds
Hundreds of dollars
Price movers
Purity method, salt form, lot linkage, quantity
Assistance, insurance, channel
Documentation
COA (varies by supplier)
FDA label, GMP trail
Intended customer
Laboratories
Patients via prescribers
Guidance on this site
None — market analysis
None — market analysis
Table: elamipretide cost parameters across the two channels. — compiled from public regulatory and academic sources; verify against the original documents before use.
It depends entirely on the channel. Research-grade ss-31 catalog material runs roughly £30–94 per 10 mg in published listings; the approved product (forzinity) carries a list-price data point around $59,636 per 14 mL supply. The channels differ in law, documentation and intended use — this page compares them as market data, without purchase guidance.
References
Research-catalog public price listings for ss-31/elamipretide (collected 2025–2026).